Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited)

v3.21.2
Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Series E Convertible Preferred Stock
Series F Convertible Preferred Stock
July 2020 Warrants
June 2020 Warrants
Common Stock
Common Stock
Series E Convertible Preferred Stock
Common Stock
Series F Convertible Preferred Stock
Common Stock
June 2020 Warrants
Additional Paid-in Capital
Additional Paid-in Capital
Series E Convertible Preferred Stock
Additional Paid-in Capital
Series F Convertible Preferred Stock
Additional Paid-in Capital
July 2020 Warrants
Additional Paid-in Capital
June 2020 Warrants
Convertible Preferred Stock
Convertible Preferred Stock
Series F Convertible Preferred Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Mezzanine Equity
Series E Convertible Preferred Stock
Beginning balance at Dec. 31, 2019 $ 377         $ 31       $ 235,594             $ (701) $ (234,547)  
Beginning balance at Dec. 31, 2019                                     $ 3,965
Beginning balance, shares at Dec. 31, 2019                                     70,000
Balance (in shares) at Dec. 31, 2019           31,459,000                          
Issuance of convertible preferred stock in rights offering, net of offering costs     $ 2,411                         $ 2,411      
Issuance of convertible preferred stock in rights offering, net of offering costs, shares                               18,000      
Beneficial conversion on Convertible Preferred Stock                       $ 2,700       $ (2,700)      
Conversion of convertible preferred stock   $ 3,965         $ 7 $ 43     $ 3,958 16,905       $ (16,948)     $ (3,965)
Conversion of convertible preferred stock, shares             6,957,000 42,370,000               (17,000)     (70,000)
Sale of common stock 3,872         $ 11       3,861                  
Sale of common stock, shares           10,800,000                          
Sale of common stock warrants 3,031     $ 9,450           3,031     $ 9,450            
Issuance of restricted shares 164                                    
Deemed Dividend on Convertible Preferred Stock (17,378)                     (17,378)       $ 17,378      
Stock offering costs (856)                 (856)                  
Stock-based compensation 1,846                 1,846                  
Warrants issued in connection with debt instruments 67                 67                  
Issuance of stock from RSUs, net 162         $ 1       161                  
Issuance of stock from RSUs, net, shares           1,297,000                          
Exercise of common stock warrants         $ 46                 $ 46          
Exercise of common stock warrants, shares                 116,000                    
Net loss (10,687)                                 (10,687)  
Foreign currency translation adjustments 167                               167  
Ending balance at Sep. 30, 2020 13,851         $ 93       259,385         $ 141   (534) (245,234)  
Balance (in shares) at Sep. 30, 2020           92,999,000                          
Ending balance, shares at Sep. 30, 2020                             1,000        
Beginning balance at Dec. 31, 2019 377         $ 31       235,594             (701) (234,547)  
Beginning balance at Dec. 31, 2019                                     $ 3,965
Beginning balance, shares at Dec. 31, 2019                                     70,000
Balance (in shares) at Dec. 31, 2019           31,459,000                          
Sale of common stock, shares     17,000                                
Ending balance at Dec. 31, 2020 $ 10,028         $ 98       261,573           $ 118 (385) (251,376)  
Balance (in shares) at Dec. 31, 2020 97,709,000         97,709,000                          
Ending balance, shares at Dec. 31, 2020 0   882                         1,000      
Beginning balance at Jun. 30, 2020 $ 1,308         $ 50       247,149             (645) (245,246)  
Balance (in shares) at Jun. 30, 2020           50,322,000                          
Issuance of convertible preferred stock in rights offering, net of offering costs     $ 2,411                         $ 2,411      
Issuance of convertible preferred stock in rights offering, net of offering costs, shares                               18,000      
Beneficial conversion on Convertible Preferred Stock                       2,700       $ (2,700)      
Conversion of convertible preferred stock               $ 43       16,905       $ (16,948)      
Conversion of convertible preferred stock, shares               42,370,000               (17,000)      
Sale of common stock warrants       $ 9,450                 $ 9,450            
Deemed Dividend on Convertible Preferred Stock (17,378)                     $ (17,378)       $ 17,378      
Stock-based compensation 513                 513                  
Issuance of stock from RSUs, net, shares           191,000                          
Exercise of common stock warrants         $ 46                 $ 46          
Exercise of common stock warrants, shares                 116,000                    
Net loss 12                                 12  
Foreign currency translation adjustments 111                               111    
Ending balance at Sep. 30, 2020 13,851         $ 93       259,385         $ 141   (534) (245,234)  
Balance (in shares) at Sep. 30, 2020           92,999,000                          
Ending balance, shares at Sep. 30, 2020                             1,000        
Beginning balance at Dec. 31, 2020 $ 10,028         $ 98       261,573           $ 118 (385) (251,376)  
Beginning balance, shares at Dec. 31, 2020 0   882                         1,000      
Balance (in shares) at Dec. 31, 2020 97,709,000         97,709,000                          
Conversion of convertible preferred stock           $ 2       628           $ (630)      
Conversion of convertible preferred stock, shares           1,577,000                   (1,000)      
Sale of common stock $ 13,291         $ 14       13,277                  
Sale of common stock, shares     18,000     14,000,000                          
Exercise of stock option Shares 176,000         176,000                          
Exercise of stock option $ 66                 66                  
Issuance of restricted shares, Shares           260,000                          
Issuance of restricted shares                   164                  
Issuance of common stock for settlement of liability 510         $ 1       509                  
Issuance of common stock for settlement of liability, Shares           500,000                          
Deemed Dividend on Convertible Preferred Stock (546)                 (546)           $ 546      
Stock-based compensation 2,253                 2,253                  
Issuance of stock from RSUs, net           $ 3       (3)                  
Issuance of stock from RSUs, net, shares           3,381,000                          
Exercise of common stock warrants 15,062         $ 35       15,027                  
Exercise of common stock warrants, shares           35,719,000                          
Net loss (10,879)                                 (10,879)  
Foreign currency translation adjustments (173)                               (173)    
Ending balance at Sep. 30, 2021 $ 30,322         $ 153       292,948           34 (558) (262,255)  
Balance (in shares) at Sep. 30, 2021 153,322,000         153,322,000                          
Ending balance, shares at Sep. 30, 2021 0   251                                
Beginning balance at Jun. 30, 2021 $ 33,256         $ 151       292,517           35 (468) (258,979)  
Balance (in shares) at Jun. 30, 2021           151,236,000                          
Conversion of convertible preferred stock                   10           (10)      
Conversion of convertible preferred stock, shares           25,000                          
Exercise of stock option Shares           176,000                          
Exercise of stock option $ 66                 66                  
Issuance of restricted shares, Shares 260,000                                    
Issuance of restricted shares $ 164                 164                  
Deemed Dividend on Convertible Preferred Stock (9)                 (9)           9      
Stock-based compensation 192                 192                  
Issuance of stock from RSUs, net           $ 2       (2)                  
Issuance of stock from RSUs, net, shares           1,600,000                          
Exercise of common stock warrants 10                 10                  
Exercise of common stock warrants, shares           25,000                          
Net loss (3,276)                                 (3,276)  
Foreign currency translation adjustments (90)                               (90)    
Ending balance at Sep. 30, 2021 $ 30,322         $ 153       $ 292,948           $ 34 $ (558) $ (262,255)  
Balance (in shares) at Sep. 30, 2021 153,322,000         153,322,000                          
Ending balance, shares at Sep. 30, 2021 0   251